We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Trade smarter, not harder: Unleash your inner pro with our toolkit and live discussions.
The current RHY market cap is 17.96M. The company's latest EPS is AUD -0.0279 and P/E is -2.51.
| Year End June 29 2024 | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|
| AUD (AUD) | AUD (AUD) | AUD (AUD) | AUD (AUD) | AUD (AUD) | |
| Total Revenue | 100k | 1.11M | 2.43M | 3.1M | 1.69M |
| Operating Income | -4.06M | -6.63M | -8.82M | -8.45M | -3.86M |
| Net Income | -4.02M | -6.61M | -8.79M | -8.22M | -6.86M |
| Year End June 29 2024 | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|
| AUD (AUD) | AUD (AUD) | AUD (AUD) | AUD (AUD) | AUD (AUD) | |
| Total Assets | 2.65M | 3.07M | 8.44M | 7.7M | 1.52M |
| Total Liabilities | 803k | 1.36M | 1.07M | 1.82M | 652k |
| Total Equity | 1.84M | 1.71M | 7.37M | 5.87M | 867k |
| Year End June 29 2024 | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|
| AUD (AUD) | AUD (AUD) | AUD (AUD) | AUD (AUD) | AUD (AUD) | |
| Operating | -2.74M | -5.4M | -6.5M | -6.96M | -6.14M |
| Investing | -46k | -68k | -27k | -99k | -82k |
| Financing | -142k | 5.9M | 11.85M | 3.63M | 2.81M |
| Market Cap | 17.96M |
| Price to Earnings Ratio | -2.51 |
| Price to Sales Ratio | 10.14 |
| Price to Cash Ratio | 24.14 |
| Price to Book Ratio | 19.86 |
| Dividend Yield | - |
| Shares Outstanding | 245.98M |
| Average Volume (1 week) | 138.27k |
| Average Volume (1 Month) | 71.35k |
| 52 Week Change | -76.45% |
| 52 Week High | 0.35 |
| 52 Week Low | 0.042 |
| Spread (Intraday) | 0 (1.35%) |
| Company Name | Rhythm Biosciences Limited |
| Address |
bio21 institute melbourne, victoria 3010 |
| Website | https://www.rhythmbio.com |
| Industry | coml physical, biologcl resh (8731) |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: 1-888-992-3836 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions
Hot Features
Premium
